Arshiya Limited has Submitted to the Exchange, the audited Financial Results (Standalone) along with the Auditor Report thereon for the Quarter and Financial year ended on March 31, 2025.
ARSHIYA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.4 pts less than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Arshiya Limited, which is under Corporate Insolvency Resolution Process (CIRP) admitted on April 23, 2024, has filed its audited standalone financial results for FY 2024-25. The company reported a massive net loss of Rs. 1,09,446.03 Lakhs against total income of Rs. 2,332.53 Lakhs. Revenue from operations stood at Rs. 1,494.85 Lakhs. The company's balance sheet shows negative equity of Rs. 1,44,030.12 Lakhs with current liabilities exceeding current assets by Rs. 2,51,396.26 Lakhs. The statutory auditor ARTHA & Associates issued a Disclaimer of Opinion citing 12 material reasons including: revenue of Rs. 31,497.19 Lakhs recognized without executed contract with Ascendas Panvel FTWZ Limited, non-recognition of interest on financial liabilities during CIRP, impairment testing not conducted for PPE (Rs. 57,123.06 Lakhs), investments in subsidiaries (Rs. 1,27,679.57 Lakhs), and inventory (Rs. 16,505.97 Lakhs). Exceptional items of Rs. 1,06,820.66 Lakhs were accounted due to CIRP claims. Results were restated following NCLAT order declaring the Arshiya Rail Infrastructure Limited demerger scheme as non-est. Consolidated financial results could not be prepared as subsidiaries are also under CIRP.
This filing reveals extreme financial distress with multi-year losses exceeding Rs. 1 lakh crore, ongoing CIRP, and a disclaimer of opinion from auditors. The disclaimer of opinion, going concern uncertainty, and restatement of results signal very high risk for existing shareholders. Any recovery depends entirely on the CIRP outcome and resolution plan approval.